Di Teng Selected Research

Goiter

12/2023	Influencing Factors and New Reference Intervals of Adult Thyroid Volume in Iodine-Sufficient Areas of China.
1/2023	Changing Iodine Status and the Incidence of Thyroid Disease in Mainland China: A Prospective 20-Year Follow-Up Study.
12/2021	The Characteristics of Iodine Nutrition Status in China After 20 Years of Universal Salt Iodization: An Epidemiology Study Covering 31 Provinces.
1/2020	Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China.
1/2020	Current Iodine Nutrition Status and Prevalence of Thyroid Disorders in Tibetan Adults in an Oxygen-Deficient Plateau, Tibet, China: A Population-Based Study.
5/2002	The study of thyroid diseases in a community not using iodized salt.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Di Teng Research Topics

Disease

12	Hypothyroidism 01/2023 - 05/2002
8	Hyperthyroidism 01/2023 - 05/2002
6	Goiter 12/2023 - 05/2002
5	Thyroid Diseases (Thyroid Disease) 01/2023 - 05/2002
4	Hyperuricemia 03/2022 - 12/2020
3	Hypercholesterolemia 01/2022 - 01/2020
3	Hypertriglyceridemia 01/2022 - 01/2020
2	Thyroid Neoplasms (Thyroid Cancer) 10/2023 - 01/2021
2	Neoplasms (Cancer) 10/2023 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 01/2020
2	Thyroid Nodule (Nodule, Thyroid) 01/2022 - 01/2020
2	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2020
2	Graves Disease (Basedow Disease) 01/2021 - 01/2020
1	Glucose Intolerance 11/2023
1	Prediabetic State (Prediabetes) 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Obesity 01/2022
1	Gout 12/2020
1	Abdominal Obesity 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Postpartum Thyroiditis (Thyroiditis, Postpartum) 01/2010
1	Hemorrhage 04/2008
1	Chronic Periodontitis 04/2008
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 06/2006

Drug/Important Bio-Agent (IBA)

14	IodineIBA 12/2023 - 05/2002
4	Thyroglobulin FDA Link 01/2023 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2023 - 01/2020
3	AntibodiesIBA 01/2023 - 01/2020
3	Iodide Peroxidase (Deiodinase)IBA 01/2020 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
2	hydroxide ionIBA 01/2023 - 01/2021
2	SaltsIBA 01/2023 - 01/2021
2	LDL CholesterolIBA 01/2022 - 01/2020
2	Thyroid HormonesIBA 01/2022 - 06/2006
1	3,5-diisopropylsalicylic acid (DIPS)IBA 03/2022
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	LipidsIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Competitive Endogenous RNAIBA 01/2021
1	betaglycan (TGFBR3)IBA 01/2021
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2010
1	Estrogen ReceptorsIBA 04/2008
1	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2008
1	FluoridesIBA 04/2008
1	iodized salt (iodised salt)IBA 05/2002